TABLE 3.
Effect of cytoskeletal binding drugs on infection of GD1a-supplemented C6 cells
Treatment | % Py LTAg-positive cells |
---|---|
+GD1aa | |
None | 100 ± 5 |
Latrunculin A | 47 ± 4 |
Jasplakinolide | 36 ± 7 |
Colcemid | 12 ± 6 |
Taxol | 107 ± 10 |
All values are normalized to C6 cells without GD1a control as 100%.